Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Paggiarino Dario A. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 91,655 options to buy @ $3.26, valued at $298.8k
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2020 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 4,168 shares @ $0.8256, valued at $3.4k
Exercised 14,200 restricted stock units @ $0
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2019 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 2,450 shares @ $2.105, valued at $5.2k
06/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2019 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 4,175 shares @ $1.53, valued at $6.4k
Exercised 14,200 restricted stock units @ $0
03/21/2019 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 1,188 shares @ $2.47, valued at $2.9k
10/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2018 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 2,945 shares @ $1.86, valued at $5.5k
Exercised 10,000 restricted stock units @ $0
06/18/2018 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 42,600 restricted stock units @ $0
Granted 170,500 options to buy @ $2.04, valued at $347.8k
03/21/2018 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on pSivida Corp.
Txns: Granted 8,333 shares @ $0
06/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/03/2016 4 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on pSivida Corp.
Txns: Granted 230,000 options to buy @ $3.93, valued at $903.9k
08/03/2016 3 Paggiarino Dario A. (Chief Medical Officer) has filed a Form 3 on pSivida Corp.
02/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/27/2013 4 Paggiarino Dario A. (Sr VP & Chief Dev. Officer) has filed a Form 4 on LPATH, INC
Txns: Granted 100,000 restricted stock units @ $0
04/22/2013 3 Paggiarino Dario A. (Sr VP & Chief Dev Officer) has filed a Form 3 on LPATH, INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy